Cutaneous Lupus Erythematosus Clinical Trials

A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Anniston Alabama 36207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Arizona

Phoenix Arizona 85032

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

California

Beverly Hills California 90211

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Fullerton California 92835

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Los Angeles California 90045

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Palm Desert California 92260

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

View More ▼

San Diego California 92103

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

San Diego California 92120

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Tustin California 92780

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Tustin California 92780

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Upland California 91786

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

West Hills California 91307

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

West Hollywood California 90048

Patients are needed to participate in a clinical research study of Milatuzumab

Colorado

Denver Colorado 80230

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Florida

View More ▼

Clearwater Florida 33765

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

DeBary Florida 32713

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Orlando Florida 32806

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Sarasota Florida 34233

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Georgia

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Illinois

Chicago Illinois 60611

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Indiana

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Massachusetts

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Missouri

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Nevada

Las Vegas Nevada 89128

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

New Jersey

Summit New Jersey 07901

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

New York

Great Neck New York 11020

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

North Carolina

Charlotte North Carolina 28210

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Charlotte North Carolina 28207

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Greensboro North Carolina 27408

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Wilmington North Carolina 28401

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

View More ▼

Wilmington North Carolina 28401

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Ohio

Cincinnati Ohio 45229

Patients are needed to participate in a clinical research study of Tofacitinib to evaluate Cutaneous Lupus or Systemic Lupus Erythematosus

Columbus Ohio 43230

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Pennsylvania

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Pittsburgh Pennsylvania 15213

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

South Carolina

Charleston South Carolina 29425

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Texas

Austin Texas 78731

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Dallas Texas 75231

A clinical trial to evaluate treatments using Filgotinib, GS-9876, Filgotinib placebo and GS-9876 placebo for patients with Cutaneous Lupus Erythematosus

Virginia

Norfolk Virginia 23507

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Bulgaria

Plovdiv 4002

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Ruse 7000

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Shumen 9700

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

Sofia 1431

Patients are needed to participate in a clinical research study evaluating BIIB059 and Placebo for the treatment of Systemic Lupus Erythematosus (SLE) or Active Cutaneous Lupus Erythematosus (CLE)

China

Research Center
Various Locations International

LILAC Study For Patients with Cutaneous and/or Systemic Lupus

Germany

UPDATED

Berlin 10117

A clinical trial to evaluate treatments using GSK2646264 1% and Placebo for patients with Lupus Erythematosus, Cutaneous

Leipzig Saxony 04103

A clinical study for patients with Lupus Erythematosus, Cutaneous or Lupus Erythematosus, Discoid